Intrauterine Devices Market to Reach US$ 3460 Mn by 2025 : Bayer, Merck, Teva Pharmaceutical

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Logo

Los Angeles, CA -- (SBWire) -- 04/18/2019 --Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices.

China is the largest consumption place, with a consumption market share nearly 53% in 2016. Following Europe, Europe is the second largest consumption place with the consumption market share of 16%.

Market competition is not intense. Bayer, Merck, Teva Pharmaceutical, Allergan, etc. are the leaders of the industry, and they hold key technologies and market, with high-end customers; have been formed in the large market share in the industry.

The global Intrauterine Devices market was 2910 million US$ in 2018 and is expected to 3460 million US$ by the end of 2025, growing at a CAGR of 2.2% between 2019 and 2025.

This report studies the Intrauterine Devices market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get PDF of this report template: https://www.qyresearch.com/sample-form/form/1090459/global-intrauterine-devices-market

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Intrauterine Devices in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Bayer

Merck

Teva Pharmaceutical

Allergan

HRA Pharma

Eurogine

Yantai JiShengYaoXie

TianYi

SMB Corporation

Shenyang Liren

H & J Medical

By the product type, the market is primarily split into

Hormonal IUD

Copper IUD

By the end users/application, this report covers the following segments

Age 20-24

Age 25-34

Age 35-44

Other

Get Full Report Now at USD 3,350: https://www.qyresearch.com/settlement/pre/6b6f1dbda61daf0b2297592ba4d3b0d7,0,1,Global%20Intrauterine%20Devices%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, Inc.
1-626-295-2442
https://www.qyresearch.com/index/detail/1090459/global-intrauterine-devices-market

View this press release online at: http://rwire.com/1198460